SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma
Conditions: Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma Interventions: Drug: SNC115 injection Sponsors: Shanghai Simnova Biotechnology Co.,Ltd.; Shanghai Chest Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Brain | Cancer | Cancer & Oncology | Carcinoma | Hospitals | Lung Cancer | Neurology | Research